Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 PneumoniaYimin Dong, Dawei Ye, Bingyang Xu et al.|Clinical Infectious Diseases|2020Cited by 138
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trialKarin Hardt, Jeffrey J. Stoddard, An Vandebosch et al.|The Lancet Infectious Diseases|2022Cited by 88
FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In VitroYanlin Tan, Fei Chen|Pharmaceuticals|2023Cited by 4
mRNA-LNP vaccination orchestrates systemic immunity to control human papillomavirus-positive head and neck squamous cell carcinomaKe Qiu, Jianjun Ren, Minzi Mao et al.|Molecular Therapy — Nucleic Acids|2025Cited by 1